These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30016667)

  • 1. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP).
    Rammes G; Seeser F; Mattusch K; Zhu K; Haas L; Kummer M; Heneka M; Herms J; Parsons CG
    Neuropharmacology; 2018 Sep; 140():184-192. PubMed ID: 30016667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anaesthetic xenon partially restores an amyloid beta-induced impairment in murine hippocampal synaptic plasticity.
    Bürge M; Kratzer S; Mattusch C; Hofmann C; Kreuzer M; Parsons CG; Rammes G
    Neuropharmacology; 2019 Jun; 151():21-32. PubMed ID: 30940537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aβ aggregation modulator MRZ-99030 prevents and even reverses synaptotoxic effects of Aβ
    Rammes G; Parsons CG
    Neuropharmacology; 2020 Nov; 179():108267. PubMed ID: 32758564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
    Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
    Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
    Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
    Mol Neurobiol; 2017 Jan; 54(1):748-754. PubMed ID: 26768593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Isoflurane, Tumor Necrosis Factor-α and β-Amyloid on Long-term Potentiation in Rat Hippocampal Slices.
    Zhou R; Bickler P
    Anesth Analg; 2017 Feb; 124(2):582-587. PubMed ID: 28099324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
    Freund RK; Gibson ES; Potter H; Dell'Acqua ML
    Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalational Anesthetics Do Not Deteriorate Amyloid-β-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.
    Hofmann C; Sander A; Wang XX; Buerge M; Jungwirth B; Borgstedt L; Kreuzer M; Kopp C; Schorpp K; Hadian K; Wotjak CT; Ebert T; Ruitenberg M; Parsons CG; Rammes G
    J Alzheimers Dis; 2021; 84(3):1193-1218. PubMed ID: 34657881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
    Klyubin I; Ondrejcak T; Hayes J; Cullen WK; Mably AJ; Walsh DM; Rowan MJ
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130147. PubMed ID: 24298149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.
    Raymond CR; Ireland DR; Abraham WC
    Brain Res; 2003 Apr; 968(2):263-72. PubMed ID: 12663096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor.
    Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
    J Neurosci; 2012 Nov; 32(48):17401-6. PubMed ID: 23197731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of protein tyrosine kinases in β-amyloid protein-induced suppression of long-term potentiation in the rat hippocampal CA1 region in vivo].
    Guo F; Li XY; Wang XH; Qi JS
    Sheng Li Xue Bao; 2009 Jun; 61(3):263-71. PubMed ID: 19536439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
    Wu MN; He YX; Guo F; Qi JS
    Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
    Huang Y; Shen W; Su J; Cheng B; Li D; Liu G; Zhou WX; Zhang YX
    J Alzheimers Dis; 2017; 57(3):885-897. PubMed ID: 28269783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
    Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
    Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.
    Wang Q; Walsh DM; Rowan MJ; Selkoe DJ; Anwyl R
    J Neurosci; 2004 Mar; 24(13):3370-8. PubMed ID: 15056716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.